News
It starts with a sniffle. A mild cough. You tell yourself it’s just a cold—babies get those, right? But make no mistake. RSV ...
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent ...
Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...
COVID-19 appears to be on the rise in some parts of California as a new, highly contagious subvariant — featuring 'razor ...
The flu virus is lingering in Arizona and the season has been vicious. Pediatric flu deaths reached the highest level in ...
One in every 10 kids in the United States has asthma, a chronic breathing condition that can affect nearly every part of ...
The U.S. Food and Drug Administration expanded approval of Moderna Inc.'s (NASDAQ: MRNA) respiratory syncytial virus vaccine.
MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results